Citation Impact
Citing Papers
Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib
2014
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
2011
BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
2008
Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer
2009
Cabozantinib in Progressive Medullary Thyroid Cancer
2013
Cancer statistics, 2022
2022 Standout
Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue.
2004
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer.
2007
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System
2010
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Cancer statistics, 2023
2023 Standout
Long-Term Consequence of Elevated Thyroglobulin in Differentiated Thyroid Cancer
2012
Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma
2015
Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement
2013
Long-Term Clinical Outcome of Differentiated Thyroid Cancer Patients with Undetectable Stimulated Thyroglobulin Level One Year After Initial Treatment
2012
Genotype-phenotype correlation in multiple endocrine neoplasia type 2
2012
Cancer statistics, 2017
2017 Standout
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2024
2024 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Cancer statistics, 2019
2019 Standout
Cancer statistics, 2018
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
2016
Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases
2004
Circulating Thyrotropin Receptor mRNA as a Novel Marker of Thyroid Cancer
2010
The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers
2007
Thyroid Nodules and Cancers in Children
2005
Identification and Optimal Postsurgical Follow-Up of Patients with Very Low-Risk Papillary Thyroid Microcarcinomas
2010
Four novel RET germline variants in exons 8 and 11 display an oncogenic potential in vitro
2010
Prognostic utility of BRAF mutation in papillary thyroid cancer
2009
rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review
2005
Molecular pathology of thyroid cancer: diagnostic and clinical implications
2008
2013 European Thyroid Association Guidelines for Cervical Ultrasound Scan and Ultrasound-Guided Techniques in the Postoperative Management of Patients with Thyroid Cancer
2013
Guidelines for radioiodine therapy of differentiated thyroid cancer
2008
Radioiodine Dose for Remnant Ablation in Differentiated Thyroid Carcinoma: A Randomized Clinical Trial in 509 Patients
2004
High Prevalence of RAS Mutations in RET -Negative Sporadic Medullary Thyroid Carcinomas
2011
Thyroid cancer
2016 Standout
Synchronous Metastatic Medullary and Papillary Thyroid Carcinomas in a Patient with Germline RET Mutation: Case Report, Molecular Analysis, and Implications for Pathogenesis
2010
Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation
2004
Familial thyroid cancer: a review
2011
Bexarotene increases uptake of radioiodide in metastases of differentiated thyroid carcinoma
2006
Diagnosis of Thyroid Cancer in Children: Value of Gray-Scale and Power Doppler US
2005
A comprehensive map of molecular drug targets
2016 Standout
International Classification of Childhood Cancer, third edition
2005
Biological Relevance of Medullary Thyroid Microcarcinoma
2012
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
2012
Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study
2008
Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer
2003
Papillary Thyroid Cancer: Time Course of Recurrences During Postsurgery Surveillance
2013
Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole-body iodine scan
2006
US-guided Fine-Needle Aspiration of Thyroid Nodules: Indications, Techniques, Results
2008
The Role of MR Imaging in Detecting Nodal Disease in Thyroidectomy Patients with Rising Thyroglobulin Levels
2008
Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition
2006
A Single Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Measurement Predicts Differentiated Thyroid Carcinoma Metastases Three to Five Years Later
2005
Thyroid-hormone therapy and thyroid cancer: a reassessment
2005
Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells
2017
Occult Contralateral Carcinoma in Patients with Unilateral Papillary Thyroid Microcarcinoma
2010
Does an undetectable rhTSH‐stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission?
2010
Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake
2004
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer
2005
Adjuvant Radioactive Therapy after Reoperation for Locoregionally Recurrent Papillary Thyroid Cancer in Patients Who Initially Underwent Total Thyroidectomy and High-Dose Remnant Ablation
2011
Differentiated thyroid carcinoma: defining new paradigms for postoperative management
2013
Phantoms in the Assay Tube: Heterophile Antibody Interferences in Serum Thyroglobulin Assays
2003
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Long-Term Survival in Differentiated Thyroid Cancer Is Worse After Low-Activity Initial Post-Surgical131I Therapy in Both High- and Low-Risk Patients
2014
Technology Insight: measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer
2008
Recombinant Human Thyroid-Stimulating Hormone To Stimulate 131-1 Uptake For Remnant Ablation And Adjuvant Therapy
2012
Comparison of completion thyroidectomy and primary surgery for differentiated thyroid carcinoma
2003
Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report
2005
Pacientes tratados por carcinoma diferenciado de tiroides con rastreos de 131I negativos y niveles de tiroglobulina elevada. Una evolución posible
2007
Management of hereditary medullary thyroid carcinoma
2016
Well‐differentiated thyroid carcinoma: The role of post‐operative radioactive iodine administration
2012
Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update
2013
Follow up Approaches in Thyroid Cancer: A Risk Adapted Paradigm
2008
Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto‐oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal
2006
Tumour heterogeneity in the clinic
2013 Nature
Are we really at the dawn of understanding sporadic pediatric thyroid carcinoma?
2015
Is the Serum Thyroglobulin Response to Recombinant Human Thyrotropin Sufficient, by Itself, to Monitor for Residual Thyroid Carcinoma?
2002
Thyroid Neoplasia, Autoimmune Thyroiditis, and Hypothyroidism in Persons Exposed to Iodine 131 From the Hanford Nuclear Site
2004
Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer
2007
Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice
2004
Neck recurrence from thyroid carcinoma: serum thyroglobulin and high‐dose total body scan are not reliable criteria for cure after radioiodine treatment
2005
Germline Homozygous Mutations at Codon 804 in theRETProtooncogene in Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia Type 2A Patients
2005
Thyroid Imaging Reporting and Data System for US Features of Nodules: A Step in Establishing Better Stratification of Cancer Risk
2011 Standout
Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole‐body scan: comparative study
2003
A novel de novo germ‐line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization
2009
Surgery for Papillary Thyroid Carcinoma
2010
Diagnostic value of thyroglobulin assay in cervical lymph node fine-needle aspirations for metastatic differentiated thyroid cancer
2012
Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer
2011
Serum thyroglobulin concentrations predict disease‐free remission and death in differentiated thyroid carcinoma
2006
Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin
2003
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
2010
BRAF V600E Mutation Independently Predicts Central Compartment Lymph Node Metastasis in Patients with Papillary Thyroid Cancer
2012
Undetectable Thyroglobulin in Patients With Differentiated Thyroid Carcinoma and Residual Radioiodine Uptake on a Postablation Whole-Body Scan
2011
Radioiodine Treatment with 30 mCi after Recombinant Human Thyrotropin Stimulation in Thyroid Cancer: Effectiveness for Postsurgical Remnants Ablation and Possible Role of Iodine Content inl -Thyroxine in the Outcome of Ablation
2003
Influence of age and primary tumor size on the risk for residual/recurrent well‐differentiated thyroid carcinoma
2009
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules.
2006
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Das medulläre Schilddrüsenkarzinom
2015
Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma
2003
Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy
2006
Progress in molecular-based management of differentiated thyroid cancer
2013
Thyroid Cancer in Children
2007
Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives
2015
Circulating thyroglobulin mRNA does not predict early and midterm recurrences in patients undergoing thyroidectomy for cancer
2008
Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients
2011
Employing Genetic Markers to Improve Diagnosis of Thyroid Tumor Fine Needle Biopsy
2011
Prognostic Factors Associated with the Survival of Patients Developing Loco-Regional Recurrences of Differentiated Thyroid Carcinomas
2004
Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients
2006
Management of Differentiated Thyroid Cancer with Rising Thyroglobulin and Negative Diagnostic Radioiodine Whole Body Scan
2010
Recombinant Human TSH–Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal
2008
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
2016
Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns
2010
How reliable is secondary risk stratification with stimulated thyroglobulin in patients with differentiated thyroid carcinoma?
2013
Evaluation of circulating thyroid‐specific transcripts as markers of thyroid cancer relapse
2004
Mainstreaming genetic testing of cancer predisposition genes
2014
Detection of Metastatic Cervical Lymph Nodes in Recurrent Papillary Thyroid Carcinoma
2009
Sonographic Imaging of Thyroid Nodules and Cervical Lymph Nodes
2008
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
2015 Standout
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Selective Activation of Somatostatin Receptor Subtypes Differentially Modulates Secretion and Viability in Human Medullary Thyroid Carcinoma Primary Cultures: Potential Clinical Perspectives
2006
No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
2009
Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients ≥ 45 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and Normal in All Other DTC Patients
2012
Positive Predictive Value of Serum Thyroglobulin Levels, Measured during the First Year of Follow-Up after Thyroid Hormone Withdrawal, in Thyroid Cancer Patients
2003
Management of Papillary Thyroid Cancer Patients in Absence of Postoperative Radioiodine Remnant Ablation: Tailoring Follow-Up by Neck Sonography
2011
Sonographic Findings in the Surgical Bed After Thyroidectomy
2007
Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors
2004
Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma
2012
New therapeutic advances in the management of progressive thyroid cancer
2009
The Clinical Spectrum of Multiple Endocrine Neoplasia Type 2a Caused by the Rare IntracellularRETMutation S891A
2010
Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma
2011
Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation
2009
Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer
2007
Risk-reduction surgery in pediatric surgical oncology: A perspective
2016
Low-Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A Systematic Review of the Literature
2015
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
2007 Standout
Does radioiodine therapy have disadvantageous effects in non‐iodine accumulating differentiated thyroid carcinoma?
2002
Management of medullary thyroid carcinoma and MEN2 syndromes in childhood
2011
Cytotoxic Effects of Carboplatinum and Epirubicin in the Setting of an Elevated Serum Thyrotropin for Advanced Poorly Differentiated Thyroid Cancer
2002
A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster
2003
Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)
2015
Which thyroid cancer patients need periodic stimulation tests?
2006
A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening
2006
Management of Recurrent/Persistent Nodal Disease in Patients with Differentiated Thyroid Cancer: A Critical Review of the Risks and Benefits of Surgical Intervention Versus Active Surveillance
2014
Comparative Evaluation of Recombinant Human Thyrotropin-Stimulated Thyroglobulin Levels,131I Whole-Body Scintigraphy, and Neck Ultrasonography in the Follow-Up of Patients with Papillary Thyroid Microcarcinoma Who Have Not Undergone Radioiodine Therapy
2006
Large Discrepancy in the Results of Sensitive Measurements of Thyroglobulin Antibodies in the Follow-Up on Thyroid Cancer: A Diagnostic Dilemma
2012
Serum Thyroglobulin Levels at the Time of131I Remnant Ablation Just after Thyroidectomy Are Useful for Early Prediction of Clinical Recurrence in Low-Risk Patients with Differentiated Thyroid Carcinoma
2005
Radiation Dose-Response Relationships for Thyroid Nodules and Autoimmune Thyroid Diseases in Hiroshima and Nagasaki Atomic Bomb Survivors 55-58 Years After Radiation Exposure
2006
Printable organometallic perovskite enables large-area, low-dose X-ray imaging
2017 StandoutNature
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
When Is Prophylactic Thyroidectomy Indicated for Patients with the RET Codon 609 Mutation?
2009
Do All Cancers Need to Be Treated? The Role of Thyroglobulin in the Management of Thyroid Cancer
2007
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective
2004
Low thyroglobulin concentrations after thyroidectomy increase the prognostic value of undetectable thyroglobulin levels on levo-thyroxine suppressive treatment in low-risk differentiated thyroid cancer
2009
Advances in the follow-up of differentiated or medullary thyroid cancer
2012
rhTSH-aided low-activity versus high-activity regimens of radioiodine in residual ablation for differentiated thyroid cancer
2013
Management of advanced medullary thyroid cancer
2015
Radiation-induced thyroid cancer: What we have learned from Chernobyl
2006
Follicular Cell-Derived Thyroid Cancer in Children
2005
Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience
2016
Multiple endocrine neoplasia type 2 and the RET protooncogene: From bedside to bench to bedside
2005
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
2014 StandoutNobel
Should ‘low‐risk’ thyroid cancer patients with residual thyroglobulin be re‐treated with iodine 131?
2006
Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk patients
2008
Follow-Up of Low Risk Patients with Papillary Thyroid Cancer: Role of Neck Ultrasonography in Detecting Lymph Node Metastases
2004
Prognostic relevance of previous exposure to ionizing radiation in well-differentiated thyroid cancer
2003
Long-term outcome of lobar ablation versus completion thyroidectomy in differentiated thyroid cancer
2010
The Role of Recombinant Human Thyrotropin for Diagnostic Monitoring of Patients with Differentiated Thyroid Cancer
2013
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
2004
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Prevalence and Clinical Spectrum of Nonsecretory Medullary Thyroid Carcinoma in a Series of 839 Patients with Sporadic Medullary Thyroid Carcinoma
2012
Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series
2012
Radioactive Iodine Administered for Thyroid Remnant Ablation Following Recombinant Human Thyroid Stimulating Hormone Preparation Also Has an Important Adjuvant Therapy Function
2010
Outcomes and Prognostic Factors of 251 Patients with Minimally Invasive Follicular Thyroid Carcinoma
2012
Positive Predictive Value of Detectable Stimulated Tg During the First Year After Therapy of Thyroid Cancer and the Value of Comparison with Tg-Ablation and Tg Measured After 24 Months
2006
A Large Multicenter Correlation Study of Thyroid Nodule Cytopathology and Histopathology
2010
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Predictive Value of Recombinant Human TSH Stimulation and Neck Ultrasonography in Differentiated Thyroid Cancer Patients
2008
BRAF V600E Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis
2015
Thyroglobulin in the Washout Fluid of Lymph-Node Biopsy: What Is Its Role in the Follow-Up of Differentiated Thyroid Carcinoma?
2013
Clinical Features and Therapeutic Implication of Papillary Thyroid Microcarcinoma
2007
Prognostic Factors Affecting Neck Lymph Node Recurrence and Distant Metastasis in Papillary Microcarcinoma of the Thyroid: Results of a Study in 445 Patients
2009
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Current Controversies in the Management of Pediatric Patients with Well-Differentiated Nonmedullary Thyroid Cancer: A Review
2002
Sequential Follow-up of Serum Thyroglobulin and Whole Body Scan in Thyroid Cancer Patients without Initial Metastasis
2006
Low Prevalence of the Somatic M918T RET Mutation in Micro-Medullary Thyroid Cancer
2012
Clinical Value of Different Responses of Serum Thyroglobulin to Recombinant Human Thyrotropin in the Follow-Up of Patients with Differentiated Thyroid Carcinoma
2005
Ultrasonographically Detected Small Thyroid Bed Nodules Identified After Total Thyroidectomy for Differentiated Thyroid Cancer Seldom Show Clinically Significant Structural Progression
2011
The Value of Diagnostic Whole-Body Scanning and Serum Thyroglobulin in the Presence of Elevated Serum Thyrotropin During Follow-Up of Anti-Thyroglobulin Antibody–Positive Patients with Differentiated Thyroid Carcinoma Who Appeared to Be Free of Disease After Total Thyroidectomy and Radioactive Iodine Ablation
2012
Quality of Life and Effectiveness Comparisons of Thyroxine Withdrawal, Triiodothyronine Withdrawal, and Recombinant Thyroid-Stimulating Hormone Administration for Low-Dose Radioiodine Remnant Ablation of Differentiated Thyroid Carcinoma
2010
Clinical Behavior of Radiation-Induced Thyroid Cancer: Factors Related to Recurrence
2009
Serum Basal Thyroglobulin Measured by a Second-Generation Assay Correlates with the Recombinant Human Thyrotropin–Stimulated Thyroglobulin Response in Patients Treated for Differentiated Thyroid Cancer
2010
Thyroid Lobe Ablation with Radioactive Iodine as an Alternative to Completion Thyroidectomy After Hemithyroidectomy in Patients with Follicular Thyroid Carcinoma: Long-Term Follow-Up
2012
Postradioiodine Treatment Whole-Body Scan in the Era of 18-Fluorodeoxyglucose Positron Emission Tomography for Differentiated Thyroid Carcinoma with Elevated Serum Thyroglobulin Levels
2012
Advances in Ultrasound for the Diagnosis and Management of Thyroid Cancer
2009
Hobnail Variant of Papillary Thyroid Carcinoma: An Institutional Case Series and Molecular Profile
2014
Detection of the BRAF V600E Mutation in Fine Needle Aspiration Cytology of Thyroid Papillary Microcarcinoma Cells Selected by Manual Macrodissection: An Easy Tool to Improve the Preoperative Diagnosis
2011
Recombinant Human Thyroid Stimulating Hormone–Assisted Radioactive Iodine Remnant Ablation in Thyroid Cancer Patients at Intermediate to High Risk of Recurrence
2012
The Effectiveness of Radioactive Iodine for Treatment of Low-Risk Thyroid Cancer: A Systematic Analysis of the Peer-Reviewed Literature from 1966 to April 2008
2010
Role of Neck Ultrasonography in the Follow-Up of Children Operated on for Thyroid Papillary Cancer
2003
Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype-phenotype correlation: an appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilian families.
2013
Thyroglobulin in Washout Fluid From Lymph Node Fine-needle Aspiration Biopsy in Papillary Thyroid Cancer: Large-scale Validation of the Cutoff Value to Determine Malignancy and Evaluation of Discrepant Results
2013
Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987–2012
2015
Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present
2007
Surgeon-Performed Ultrasound in the Management of Thyroid Malignancy
2004
RET/PTC Rearrangements in Thyroid Nodules: Studies in Irradiated and Not Irradiated, Malignant and Benign Thyroid Lesions in Children and Adults1
2001
Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin‐stimulation test?
2012
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
2006
The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma.
2011
Screening for Thyroid Cancer
2017
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
131I Activity for Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Systematic Review
2006
Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy
2006
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
The Effectiveness of Recombinant Human Thyroid-Stimulating Hormone versus Thyroid Hormone Withdrawal Prior to Radioiodine Remnant Ablation in Thyroid Cancer: A Meta-Analysis of Randomized Controlled Trials
2014
Radioiodine therapy for patients with differentiated thyroid cancer after thyroidectomy: direct comparison and network meta-analyses.
2013
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Can we interpret serum thyroglobulin results?
2012
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
2006
Ultrasound Criteria of Malignancy for Cervical Lymph Nodes in Patients Followed Up for Differentiated Thyroid Cancer
2007
Screening for Colorectal Cancer
2016 Standout
Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
2005
A Comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-Iodine Administered Doses for Recombinant Thyrotropin-Stimulated Postoperative Thyroid Remnant Ablation in Differentiated Thyroid Cancer
2007
Medullary thyroid cancer diagnosis: An appraisal
2013
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2014 Standout
Pathogenesis, diagnosis and management of thyroid nodules in children
2006
Response of thyroglobulin to radioiodine therapy in thyroglobulin-elevated negative iodine scintigraphy (TENIS) syndrome.
2011
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer
2010
Thyroid Cancer Gender Disparity
2010
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years
2012
Empiric High-Dose 131-Iodine Therapy Lacks Efficacy for Treated Papillary Thyroid Cancer Patients with Detectable Serum Thyroglobulin, but Negative Cervical Sonography and 18F-Fluorodeoxyglucose Positron Emission Tomography Scan
2010
MRI Versus 131I Whole-Body Scintigraphy for the Detection of Lymph Node Recurrences in Differentiated Thyroid Carcinoma
2010
Management of Low-Risk Differentiated Thyroid Cancer
2007
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
The Impact of Age and Gender on Papillary Thyroid Cancer Survival
2012
The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
2005
Cancer treatment and survivorship statistics, 2019
2019 Standout
Current Strategies for Surgical Management and Adjuvant Treatment of Childhood Papillary Thyroid Carcinoma
2004
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Lack of Impact of Radioiodine Therapy in Tg-Positive, Diagnostic Whole-Body Scan-Negative Patients with Follicular Cell-Derived Thyroid Cancer
2002
Approach to the Patient with a Positive Serum Thyroglobulin and a Negative Radioiodine Scan after Initial Therapy for Differentiated Thyroid Cancer
2008
Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis
2005
Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases
2009
A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma
2003
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Occupational Exposure to Ionizing Radiation Is Associated with Autoimmune Thyroid Disease
2005
Monitoring Thyroglobulin in a Sensitive Immunoassay Has Comparable Sensitivity to Recombinant Human TSH-Stimulated Thyroglobulin in Follow-Up of Thyroid Cancer Patients
2006
Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer.
2004
Exposing the Thyroid to Radiation: A Review of Its Current Extent, Risks, and Implications
2010
Diversity of mutations in theRETproto-oncogene and its oncogenic mechanism in medullary thyroid cancer
2015
Guidelines for the management of thyroid cancer
2014 Standout
Factors Influencing the Basal and Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin in Patients with Metastatic Thyroid Carcinoma
2004
Novel tandem germline RET proto‐oncogene mutations in a patient with multiple endocrine neoplasia type 2B: Report of a case and a literature review of tandem RET mutations with in silico analysis
2013
Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
2008
Current Update on Medullary Thyroid Carcinoma
2013
Cost-Effectiveness of FDG-PET/CT for Cytologically Indeterminate Thyroid Nodules: A Decision Analytic Approach
2014
Medullary thyroid carcinoma: a review on ethical considerations in treatment of children
2016
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
2005
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
Limited Value of Repeat Recombinant Human Thyrotropin (rhTSH)-Stimulated Thyroglobulin Testing in Differentiated Thyroid Carcinoma Patients with Previous Negative rhTSH-Stimulated Thyroglobulin and Undetectable Basal Serum Thyroglobulin Levels
2007
Cancer treatment and survivorship statistics, 2014
2014 Standout
Challenges of Serum Thyroglobulin (Tg) Measurement in the Presence of Tg Autoantibodies
2004
BRAFV600E Mutation Analysis in Papillary Thyroid Carcinoma: Is it Useful for all Patients?
2013
Works of Laura Agate being referenced
RET Genetic Screening in Patients with Medullary Thyroid Cancer and Their Relatives: Experience with 807 Individuals at One Center
2007
Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study
2007
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer
2011
Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer
2015
Post-Chernobyl Thyroid Carcinoma in Belarus Children and Adolescents: Comparison with Naturally Occurring Thyroid Carcinoma in Italy and France1
1997
Identification of a Novel Point Mutation in the RET Gene (Ala883Thr), Which Is Associated with Medullary Thyroid Carcinoma Phenotype Only in Homozygous Condition
2004
Prediction of Disease Status by Recombinant Human TSH-Stimulated Serum Tg in the Postsurgical Follow-Up of Differentiated Thyroid Carcinoma
2001
All-Trans-Retinoic Acid Treatment Inhibits the Growth of Retinoic Acid Receptor β Messenger Ribonucleic Acid Expressing Thyroid Cancer Cell Lines but Does Not Reinduce the Expression of Thyroid-Specific Genes
2005
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
2010
Treatment of advanced thyroid cancer with targeted therapies: ten years of experience
2016
Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Combined with Neck Ultrasonography Has the Highest Sensitivity in Monitoring Differentiated Thyroid Carcinoma
2003
Prophylactic Central Compartment Lymph Node Dissection in Papillary Thyroid Carcinoma: Clinical Implications Derived From the First Prospective Randomized Controlled Single Institution Study
2015
Low Specificity of Blood Thyroglobulin Messenger Ribonucleic Acid Assay Prevents Its Use in the Follow-Up of Differentiated Thyroid Cancer Patients
2004
Contralateral Papillary Thyroid Cancer is Frequent at Completion Thyroidectomy with No Difference in Low- and High-Risk Patients
2001
The Timing of Total Thyroidectomy in RET Gene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center
2011
Prevalence of thyroid autoantibodies in children and adolescents from Belarus exposed to the Chernobyl radioactive fallout
1998
RET protein expression has no prognostic impact on the long-term outcome of papillary thyroid carcinoma
2001
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer
2008
Are the Clinical and Pathological Features of Differentiated Thyroid Carcinoma Really Changed over the Last 35 Years? Study on 4187 Patients from a Single Italian Institution to Answer this Question
2010
Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality‐of‐life assessments
2014
Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity 131I After Either Recombinant Human TSH or Thyroid Hormone Therapy Withdrawal Showed the Same Outcome After a 10-Year Follow-up
2013
New and old knowledge on differentiated thyroid cancer epidemiology and risk factors.
2012
Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
2014
TheBRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study
2012
Thyroid Autoantibodies and Thyroid Function in Subjects Exposed to Chernobyl Fallout during Childhood: Evidence for a Transient Radiation-Induced Elevation of Serum Thyroid Antibodies without an Increase in Thyroid Autoimmune Disease
2008
Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy.
2009
Ablation of Thyroid Residues with 30 mCi 131I: A Comparison in Thyroid Cancer Patients Prepared with Recombinant Human TSH or Thyroid Hormone Withdrawal
2002
Outcome of Differentiated Thyroid Cancer with Detectable Serum Tg and Negative Diagnostic 131I Whole Body Scan: Comparison of Patients Treated with High 131I Activities Versus Untreated Patients
2001